Rixensart, Belgium

Stephane Rioux

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephane Rioux. Retrieved from https://idiyas.com/inventor/stephane-rioux-1qfcq7m5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephane Rioux

Introduction

Stephane Rioux is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of medical treatments, particularly in addressing streptococcal infections. His work has implications for improving patient outcomes and advancing medical science.

Latest Patents

Stephane Rioux holds a patent for the treatment of streptococcal infections. The patent describes methods of treating this type of infection, showcasing his innovative approach to tackling a common yet serious health issue. He has 1 patent to his name, reflecting his commitment to advancing medical knowledge.

Career Highlights

Rioux is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. His role there allows him to collaborate with other experts and contribute to groundbreaking research in the field of medicine.

Collaborations

Throughout his career, Stephane Rioux has worked alongside talented colleagues, including Philippe Denoel and Philippe Vincent Hermand. These collaborations have likely enriched his research and led to innovative solutions in treating infections.

Conclusion

Stephane Rioux's contributions to the treatment of streptococcal infections highlight his role as an important inventor in the medical field. His work continues to influence advancements in healthcare and patient treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…